Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trialsRobert K. Hills, Alan K. Burnett, Megan Othus et al.|The Lancet Oncology|2014Cited by 703